COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn PVP-IPVP-I FLVFLV REGNR2 LY-CoVLY RemdesivirRMD
HCQ study #69 of 260
6/22 Safety
Isaksen et al., medRxiv, doi:10.1101/2020.06.19.20135475 (Preprint)
Chloroquine, but not hydroxychlorquine, prolongs the QT interval in a primary care population
Source   PDF   Share   Tweet
Safety analysis in patients without COVID-19, finding a small increase in QTc associated with use of CQ, but not HCQ. Authors also study mortality (n=3,368), with HCQ hazard ratio 0.67 [0.43-1.05].

Isaksen et al., 6/22/2020, preprint, 5 authors.
Details of all 260 studies    Meta analysis
Please send us corrections, updates, or comments.
Submit